CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +141,753 | 141,753 | ||
| 2017-12-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +15,150 | 15,150 | ||
| 2017-12-31 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +34,653 | 34,653 | ||
| 2017-12-31 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +34,653 | 34,653 | ||
| 2017-12-31 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +24,752 | 24,752 | ||
| 2017-12-31 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +15,150 | 15,150 | ||
| 2017-11-10 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +28,316 | 28,316 | ||
| 2017-09-30 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +3,440 | 3,440 | ||
| 2017-09-30 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +3,440 | 3,440 | ||
| 2017-09-30 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +3,440 | 3,440 | ||
| 2017-09-30 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +3,440 | 3,440 | ||
| 2017-09-30 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +3,440 | 3,440 | ||
| 2017-06-30 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +3,402 | 3,402 | ||
| 2017-06-30 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +3,402 | 3,402 | ||
| 2017-06-30 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +3,402 | 3,402 | ||
| 2017-06-30 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +3,402 | 3,402 | ||
| 2017-06-30 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +3,402 | 3,402 | ||
| 2017-06-22 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +182,824 | 182,824 | ||
| 2017-06-22 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +376,886 | 376,886 | ||
| 2017-06-22 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 |
Page 17 of 20 · 384 trades